ORIGINAL RESEARCH article
Front. Oncol.
Sec. Molecular and Cellular Oncology
BAG3 in human tumors
Provisionally accepted- 1Universita degli Studi di Salerno Dipartimento di Medicina Chirurgia e Odontoiatria Scuola Medica Salernitana, Baronissi, Italy
- 2Universita degli Studi Gabriele d'Annunzio Chieti Pescara Dipartimento di Tecnologie Innovative in Medicina & Odontoiatria, Chieti, Italy
- 3Universita degli Studi di Salerno, Fisciano, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Previous studies identified BAG3 as a stress-induced protein with pro-survival functions in various tumors. Based on this assumption, we analyzed the expression and secretion of BAG3 in 24 cancer cell lines representing ten types of cancer and compared these results with samples from primary tumors. BAG3 was ubiquitously expressed and secreted by all cell lines. Serum levels of BAG3 were significantly elevated in patients with liver, pancreatic, and ovarian cancers versus healthy controls. Immunohistochemical analysis confirmed widespread high BAG3 expression across multiple tumor types, often correlating with tumor grade. These data support BAG3 as a key regulator of tumor survival and a promising biomarker and therapeutic target.
Keywords: BAG31, Tumor2, cancer cell lines3, Human serum4, biomarker5
Received: 15 Oct 2025; Accepted: 31 Oct 2025.
Copyright: © 2025 Manzo, Cammarota, Dimitrov, Rosati, Marzullo, Turco, De Laurenzi, Sala, De Marco and Basile. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Margot  De Marco, mdemarco@unisa.it
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
